Massive Pulmonary Thromboembolism Due To Activated Protein C Resistance and Protein S Deficiency
PDF
Cite
Share
Request
Case report
VOLUME: 7 ISSUE: 3
P: 126 - 130
December 2006

Massive Pulmonary Thromboembolism Due To Activated Protein C Resistance and Protein S Deficiency

1. Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey
2. Atatürk Chest Diseaes and Chest Surgery Education and Research Hospital, Pulmonology, Ankara, Turkey
3. Atatürk Training and Research Hospital for Chest Diseases and Thoracic Surgery, Department of Chest Disease, Ankara, Turkey
No information available.
No information available
Accepted Date: 13.10.2021
Online Date: 13.10.2021
Publish Date: 13.10.2021
PDF
Cite
Share
Request

Abstract

A 38-year-old woman, who presented with pulmonary embolism as­sociated with thrombi in the main pulmonary arteries and enlarged right-sided chambers, was discovered to have both activated protein C resistance (APCR) and protein S deficiency. She had a heterozygous mutation for factor V Leiden. Especially in young individuals under 45 years of age and in the absence of risk factors, inherited prothrombotic defects should be considered. Hereditary APCR accounts for more thrombotic events than the other inherited deficiencies such as protein C and S and anti-thrombin. The presence of these factors together increases the risk and severity of thrombotic events.

Keywords:
pulmonary thromboembolism, hereditary risk factors, APC resistance, protein S deficiency